NCT05389579 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

Baker B, Lawson R
Maternal and newborn outcomes related to unplanned hypothermia in scheduled low-risk cesarean delivery births. Newborn & Infant Nursing Reviews. 2012;12(2):75-77.
Camus Y, Delva E, Bossard AE, Chandon M, Lienhart A
Prevention of hypothermia by cutaneous warming with new electric blankets during abdominal surgery. Br J Anaesth. 1997 Dec;79(6):796-7.

Evaluation of Use of Woolen Blanket Together With Electric Blanket for Controlling Postoperative Hypothermia in Total Knee Arthroplasty Patients; Surgical Nursing Programme

Details for clinical trial NCT05389579

Clinical trial NCT05389579 - References